Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment
Assessment of health-related quality of life (HRQOL) is critical to effective delivery of palliative care in patients with advanced cancer. The current study analyzes relationships between baseline social dete...
-
Article
Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases
Bone metastases from various cancers have been traditionally treated with bisphosphonates, such as zoledronic acid (ZA), to prevent future skeletal-related events (SREs). Denosumab (Dmab) has been shown to hav...